Welchol

Low folate status contributes to elevated homocysteine, a metabolite that has been associated with endothelial dysfunction, arterial stiffness, and a higher risk of stroke and coronary heart disease. Large observational studies consistently show that individuals with higher homocysteine levels have greater rates of cardiovascular events, and folate intake is one of the key nutritional determinants of homocysteine. Clinically, folic acid supplementation (often combined with vitamins B6 and B12) can lower homocysteine and appears to modestly reduce stroke risk in some populations, making the identification and correction of folate deficiency an important part of broader cardiovascular risk reduction.

Folate deficiency in the periconceptional period significantly increases the risk of neural tube defects (NTDs) such as spina bifida and anencephaly, because adequate folate is required for proper closure of the embryonic neural tube in the first month of pregnancy. Large observational datasets and randomized trials have shown that appropriate folic acid supplementation before conception and in early pregnancy can reduce NTD risk by roughly 50–70% in the general population, with even greater risk reduction in women with a prior NTD‑affected pregnancy. The practical implication is that all women of childbearing potential, not just those actively planning pregnancy, are typically advised to maintain adequate daily folic acid intake so that red‑cell folate stores are sufficient well before conception occurs.

Vitamin A deficiency can damage the surface of the eye in both children and adults, progressing from dry, uncomfortable eyes and night‑vision problems to xerophthalmia and, in severe cases, permanent blindness if it is missed. Regular vitamin A from food and, when appropriate, thoughtfully used supplements can meaningfully reduce this risk; in one large analysis, children in the highest overall intake group had about a 62 percent lower risk of xerophthalmia than those in the lowest group (multivariate relative risk 0.38, 95 percent confidence interval 0.19–0.74). Vitamin A deficiency and xerophthalmia have been documented not just in low‑resource settings but also in at‑risk children and adults in developed countries, so anyone with unexplained dry eyes, night‑vision changes, or corneal findings should have vitamin A status considered and be referred promptly for ophthalmology review to help protect their sight.

Inadequate vitamin D undermines calcium absorption and bone remodeling, so chronic deficiency increases the risk of low bone mineral density, osteoporosis, and osteomalacia with bone pain and muscle weakness. Epidemiologic data have linked low 25‑hydroxyvitamin D levels with higher rates of fragility fractures, particularly hip and vertebral fractures in older adults, even after adjusting for age and baseline bone density. Clinically, correcting vitamin D deficiency, together with adequate calcium intake, resistance exercise, and fall‑prevention strategies, has been shown to improve bone mineral density and help reduce fracture risk in at‑risk populations.

Vitamin D receptors are present in blood vessels and heart muscle, and deficiency has been linked in observational studies to higher rates of hypertension and heart failure. In large cohorts, people with low 25‑hydroxyvitamin D levels more often have elevated blood pressure and show a greater incidence of new‑onset heart failure and cardiovascular events over time, even after adjusting for some traditional risk factors. Clinically, maintaining adequate vitamin D levels is regarded as a simple, proactive way to support healthier vascular tone, blood pressure regulation, and overall cardiovascular resilience.

Vitamin D deficiency has been consistently associated with higher risk of metabolic problems, including insulin resistance and type 2 diabetes. A meta-analysis of 21 prospective studies following 76,220 participants and documenting 4,996 new type 2 diabetes cases found a clear, statistically significant inverse relationship between circulating 25(OH)D levels and future diabetes risk across diverse populations. In clinical research, people with type 2 diabetes typically show significantly lower vitamin D levels and higher HOMA-IR scores than healthy controls, with an inverse correlation between vitamin D status and insulin resistance that supports a potential mechanistic role of deficiency in the pathophysiology of insulin resistance.